Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries

Affiliations

• ¹ CREATE Centre, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
• ² Division of Rheumatology, University of Pavia and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
• ³ Department of Medicine, Universidade Federal do Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil.
• ⁴ Department of Rheumatology, APHP, Pitie Salpetriere Hospital, Pierre and Marie Curie University, Paris, France.
• ⁵ Department of Rheumatology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
• ⁶ Genentech, South San Francisco, CA, USA.
• ⁷ F. Hoffmann-La Roche, Basel, Switzerland.